Wayne P. Rothbaum - 01 Mar 2024 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Reporting relationship: Director
Issuer ticker: IOVA
Reported as of: 01 Mar 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Mar 2024, 17:56:48 UTC
Prior SEC filing: 20 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/ Wayne P.Rothbaum

Key filing fact

Wayne P. Rothbaum filed Form 4 for IOVANCE BIOTHERAPEUTICS, INC. (IOVA) on 05 Mar 2024.

Key facts

This page summarizes Wayne P. Rothbaum's Form 4 filing for IOVANCE BIOTHERAPEUTICS, INC. (IOVA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Mar 2024, 17:56.

Change

Previous filing in this sequence was filed on 20 Feb 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IOVA transaction Derivative

Deferred Restricted Stock Unit

Award

Transaction value: $0
Shares: +100,000
Change %
Price: $0.000000
Shares after: 100,000
Date: 01 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended).

Footnote F2

50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.